Nivolumab treatment for oesophageal squamous-cell carcinoma: an open-label, multicentre, phase 2 trial

Toshihiro Kudo, Yasuo Hamamoto, Ken Kato, Takashi Ura, Takashi Kojima, Takahiro Tsushima, Shuichi Hironaka, Hiroki Hara, Taroh Satoh, Satoru Iwasa, Kei Muro, Hirofumi Yasui, Keiko Minashi, Kensei Yamaguchi, Atsushi Ohtsu, Yuichiro Doki, Yuko Kitagawa

Research output: Contribution to journalArticlepeer-review

217 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Nivolumab treatment for oesophageal squamous-cell carcinoma: an open-label, multicentre, phase 2 trial'. Together they form a unique fingerprint.

Medicine & Life Sciences